The stock price of Firefly Neuroscience Inc (NASDAQ: AIFF) has surged by 15.32 when compared to previous closing price of 3.46, but the company has seen a 17.01% gain in its stock price over the last five trading sessions. newsfilecorp.com reported 2025-03-06 that A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia Calgary, Alberta–(Newsfile Corp. – March 6, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or “HEM”), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc. (NASDAQ: AIFF) (“Firefly”), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the “Phase 1”).
Is It Worth Investing in Firefly Neuroscience Inc (NASDAQ: AIFF) Right Now?
The stock has a 36-month beta value of 3.29. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AIFF is 3.26M, and at present, short sellers hold a 13.71% of that float. On March 14, 2025, the average trading volume of AIFF was 8.86M shares.
AIFF’s Market Performance
AIFF stock saw a decrease of 17.01% in the past week, with a monthly decline of -69.24% and a quarterly a decrease of 35.25%. The volatility ratio for the week is 11.19%, and the volatility levels for the last 30 days are 20.80% for Firefly Neuroscience Inc (AIFF). The simple moving average for the last 20 days is -24.07% for AIFF stock, with a simple moving average of -13.17% for the last 200 days.
AIFF Trading at -12.58% from the 50-Day Moving Average
After a stumble in the market that brought AIFF to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.80% of loss for the given period.
Volatility was left at 20.80%, however, over the last 30 days, the volatility rate increased by 11.19%, as shares sank -74.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +49.81% upper at present.
During the last 5 trading sessions, AIFF rose by +16.42%, which changed the moving average for the period of 200-days by -44.86% in comparison to the 20-day moving average, which settled at $5.25. In addition, Firefly Neuroscience Inc saw 50.57% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AIFF
Equity return is now at value -66.59, with -24.58 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.05.
Conclusion
To sum up, Firefly Neuroscience Inc (AIFF) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
